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Programmed cell death (PCD) characteristically involves chromatin condensation, membrane blebbing, and DNA oligo-
nucleosomal fragmentation. These events, collectively referred to as apoptosis, represent an active cell suicide mechanism
that eliminates cellular threats including potentially cancerous or virus-infected cells. Various types of programmed cell
death can be blocked by the proto-oncogene Bcl-2. Levels of this protein are consistently low or undetectable in human
endothelial cells (EC), which are important for immunoregulation through their interactions with circulating lymphocytes and
are potential targets for infection by virus-bearing T-cells. Accumulating evidence suggests that EC may be infected in vivo
to play an important role in HTLV-I-associated neuromyelopathy. In the present study, we report the establishment and
characterization of human endothelial cell lines stably transfected with an HTLV-I-derived molecular clone. We observed
constitutive expression of HTLV-I genes coinciding with activated Bcl-2 expression. Transient transfection of EC with the
viral transactivator Tax and a reporter construct Bcl-2 promoter-CAT did not result in a significant increase in CAT activity
and suggests that, in EC, expression of a second viral protein might be required for Bcl-2 activation. Further, Tax-induced
apoptosis in rat fibroblasts has been shown to be blocked by Bcl-2 expression. Thus, HTLV-I-mediated induction of Bcl-2
expression in EC may provide protection against viral-induced apoptosis or extend cellular survival and create a reservoir
for viral gene expression. q 1997 Academic Press
INTRODUCTION distinct cellular pathways. Tax interacts with CREB/ATF
family transcription factors and stimulates expression of
The human T-cell leukemia virus type I (HTLV-I) is the
viral genes from the 21-bp enhancers present in the
causative agent of adult T-cell leukemia/lymphoma (ATL:
HTLV-I LTR (Zhao and Giam, 1991). Additionally, Tax in-
Poeisz et al., 1980; Hinuma et al., 1981; Yoshida et al.,
teracts with key components of the IkB/NFkB signaling
1982) and a chronic neurodegenerative disease known
pathways (Beraud et al., 1994; Hirai et al., 1994; Lanoix
as tropical spastic paraparesis or HTLV-associated-my-
et al., 1994) and the serum response factor p67SRF (Fujii
elopathy (TSP/HAM: Gessain et al., 1985; Osame et al.,
et al., 1988) to activate expression of cytokines and the
1986). HTLV-I is considered to be T-lymphocyte tropic
proto-oncogene c-Fos, respectively.
and infects predominantly the helper T-cell subset in vivo
The events leading to the occurrence of HTLV-I-asso-
and in vitro. As the viral genome does not encode a
ciated myelopathy are not well understood. Accumulat-
known oncogene (Wong-Staal et al., 1985) or promote ing evidence suggests that EC might play an important
cis-activation of endogenous proto-oncogenes by site- role in TSP/HAM pathogenesis. Previous studies have
specific integration (Seiki et al., 1984), the events leading described productive infection of EC by HTLV-I (Ho et
to the occurrence and progression of a hematological or al., 1984; Hoxie et al., 1984). Leukocyte adhesion mole-
neurological disease remain to be elucidated. cules to endothelium are known to play a key role in the
The 3* end of the HTLV-I provirus harbors a region pathogenesis of inflammatory diseases. Interestingly,
known as pX that encodes two major regulatory proteins. the vascular cell adhesion molecule-1 (VCAM-1), which
The Rex protein is a posttranscriptional modulator of viral can mediate HTLV-I-induced syncitium formation (Hil-
gene expression (Inoue et al., 1986) while the trans-acti- dreth et al., 1997) is expressed at much higher levels
vating Tax protein is a transcriptional activator for the on EC in spinal cord lesions of TSP/HAM compared with
viral promoter (Felber et al., 1985; Sodrowski et al., 1985) those of noninfected individuals (Umehara et al., 1996).
as well as for numerous cellular genes involved in cell Moreover, the increased adherence of T-cells to EC that
growth and differentiation. The pleiotropic effect of Tax is observed in TSP/HAM patients (Ichinose et al., 1994)
is attributed to its ability to activate transcription through induces spontaneous proliferation and the production of
inflammatory cytokines by EC-adherent T-cells and is
proposed to be intimately involved in the immunopatho-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 295-1545. genesis of TSP/HAM (Nakamura et al., 1996). Thus, in-
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fection and/or interaction of EC with HTLV-I-infected T- resistance plasmid (Meneguzzi et al., 1984). The Bcl-2
reporter construct P1P2-CAT was kindly provided by Dr.cells may be important as an initial trigger for damage to
blood –brain barrier and T-cell-infiltration into the central G. Zauli, HTLV-I-LTR-CAT and the Tax-expressing vector
was provided by Dr. C. Z. Giam. DNA primers used fornervous system.
In order to study the effects of HTLV-I replication in PCR screening of endothelial cell clones and for Bcl-2
detection are described in Table 1.human endothelial cells, stable cell lines chronically ex-
pressing a HTLV-I TSP/HAM-derived molecular clone
Polymerase chain reaction (PCR)were generated. Characterization of these cell lines re-
vealed an association between replication of HTLV-I and One microgram of DNA was denaturated (1007 for 10
expression of the proto-oncogene Bcl-2. min) and subjected to 30 cycles of amplification (1 min
at 927, 1 min at 527, and 2 min at 727) and one cycle of
MATERIALS AND METHODS extension (7 min at 727) with Taq polymerase (1 unit,
Amerham).Cell lines
The endothelial cell lines ECV (Takahashi et al., 1990), Reverse transcription-polymerase chain reaction
ECVneo, CR4, CR5, were grown in DMEM medium sup- (RT-PCR)
plemented with 5% heat-inactivated fetal bovine serum
Total RNA (5 mg) was treated with RNAse (35 units)(Hyclone) in the presence of 100 units/ml penicillin and
in RT reaction buffer (BRL) supplemented with DTT (10100 mg/ml streptomycin, and 2 mM glutamine. ECVneo
mM) in a final volume of 10 ml for 1 hr at 377. Reversewas generated by stable transfection of the PVV1 and
transcription was performed in RT reaction buffer (BRL)cloned after neomycin selection. The cell lines JPX9 and
in the presence of dNTP mix (1 mM each), randomJPXm3 (Tatewaki et al., 1995) were treated with 20 mM
primers pdN6 (5 mg/ml), RNAsin (40 units, Boehringer-cadnium chloride (CdCl2) for 24 hr prior to protein extrac-
Mannheim), and 5 mg of treated or untreated RNA, over-tion and Western blot analysis. The follicular B-cell
night at 377. Complementary DNAs were subjected tolymphoma cells (OCI-Ly8, kindly provided by Dr. N. Be-
20 cycles of amplification (947, 1 min; 587, 2 min; 727,rinstein) were maintained in RPMI-1640 supplemented
3 min), followed by an additional 20 cycles (947, 1 min;with 10% heat-inactivated fetal bovine serum in the pres-
587, 2 min; 727, 4 min), and a single extension cycle atence of 100 units/ml penicillin, 100 mg/ml streptomycin,
727 for 7 min.and 2 mM glutamine. The HTLV-I immortalized cell line
2060 (Nicot et al., 1993) was maintained under the same
Transient transfectionconditions with the addition of 10 units/ml of IL-2.
Plasmid DNA (5 mg) was transfected into 106 Cos cells
Southern blot analysis
using DEAE-Dextran. DNA was mixed with PBS and
Ten micrograms of high molecular weight DNA was DEAE-Dextran (50 mg/ml) prior to addition to cells. Fol-
cleaved with restriction endonuclease; following electro- lowing incubation (30 min at 377), 5 ml of serum-free
phoresis, the restriction fragments were blotted onto ny- DMEM (GIBCO-BRL) supplemented with chloroquine (80
lon membranes (Amersham) and hybridized against spe- mM) was added and the cells were further incubated for
cific 32P-labeled probes. 2.5 hr at 377. The medium was subsequently replaced
by 2 ml of DMEM–(10%) DMSO for 2 min. The monolayer
Western blot analysis was washed once with DMEM and incubated in com-
plete medium for 72 hr prior to protein extraction. ECVVirus particles were purified as previously described
cells were transfected using lipofectine (Gibco-BRL), 5(Nicot et al., 1993). Proteins were resolved on SDS–poly-
mg of reporter plasmid, and 2.5 mg of Tax-expressingacrylamide gels (12.5–20%) and subsequently trans-
vector. The transfection medium was removed 16 hr laterferred to nitrocellulose. HTLV-I antigen detection was
and replaced with fresh medium. The cells were har-performed using either TSP-patient serum and 125I-pro-
vested 24 hr later, cell extracts were made by the freeze–tein A or rabbit Tax-C anti-serum and anti-rabbit horse-
thaw method, and the supernatants were used for CATradish peroxidase (HRP). Bcl-2 expression was detected
assay (Gorman et al., 1982).using a mouse monoclonal antibody and a rabbit anti-
mouse HRP secondary antibody. Substrate development
RESULTSwas accomplished using chemiluminescence (Amer-
sham). We have previously described the isolation of a func-
tional TSP-derived proviral clone (p4.39) capable of di-
Plasmids and primers
recting the synthesis of virus particles when introduced
into Cos cells (Nicot et al., 1993). In order to study theThe HTLV-I molecular clone p4.39 was isolated from
a TSP patient (Nicot et al., 1993); PVV1 is a neomycin- effects of virus replication on cellular physiology, the hu-
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concentrate any HTLV-I particles that might be released
by these cells and proteins in the pellet fraction were
analyzed by Western blotting. Results shown in Fig. 2b
indicate that the CR5 cell line is able to direct the synthe-
sis of virus particles (lane 4) whose mature proteins mi-
grate with the same mobility as those of HTLV-I particles
released from 2060 (lane 1) or Cos cells transfected by
p4.39 (lane 2). These proteins were not present in me-
dium from the parental ECV cell line (lane 3). These re-
sults indicate that we have cloned a human endothelial
cell line (CR5) expressing major HTLV-I structural pro-
FIG. 1. (a) Detection of HTLV-I proviral sequences by PCR. One teins as well as the regulatory proteins Tax and Rex.
microgram of DNA for the cell lines, CR4 (lane 1), CR5 (lane 2), ECV Infectivity and the ability of these virus particles to immor-(lane 3), and 2060 (lane 4), was subjected to PCR using two different
talize primary T-cells remain to be tested. Viral gene ex-sets of primers (pol a/pol b; tax 1/tax 2) specific for HTLV-I genes pol
pression was additionally confirmed by Western blot us-(A) and tax (B). Amplified fragments were detected by Southern blot
analysis. (b) Integration of a full-length HTLV-I provirus in human endo- ing cellular protein extracts and RT-PCR (data not
thelial cells. Southern blot analysis was performed on 10 mg of SacI- shown). CR5 has been cultured for a period in excess of
digested high molecular weight genomic DNA from each cell line. 6 months and displays stable expression of viral anti-Fragments were transferred onto a nylon membrane and hybridized
gens. The reduced level of virus protein expression inagainst a full-length HTLV-I proviral radiolabeled probe. CR4 (lane 1),
CR5 compared to that observed for HTLV-I-immortalizedCR5 (lane 2), ECV (lane 3), and 2060 (lane 4).
T-cells is consistent with previous reports showing a
general lack or reduction of HTLV-I expression in non-
lymphoid cells. At least some difficulty in achieving de-man endothelial cell line, ECV, was stably transfected by
coelectroporation of p4.39 with a neomycin-resistance tectable levels of HTLV-I antigens might reflect a cyto-
toxic effect of Tax, as earlier studies have demonstratedvector (PVV1). After 2 weeks of neomycin selection, cells
were cloned by limited dilution. Screening of these thymic atrophy in mice transgenic for the HTLV-I tax gene
(Furuta et al., 1989) and apoptotic cell death in humanclones by polymerase chain reaction, using two sets of
primers specific for HTLV-I genes pol (A) and tax (B), lymphocytes or rodent fibroblasts expressing this protein
(Yamada et al., 1994; Chlichlia et al., 1995). We havefacilitated the identification of two clones harboring these
HTLV-I sequences (Fig. 1a). To further confirm the inte- also observed apoptosis in hamster fibroblasts (BHK21)
expressing either the full-length clone p4.39 or a deriva-gration of a full-length provirus and the clonal origin of
these cell lines, DNA was extracted and subjected to tive containing only the pX region. Although CR5 cells
express the HTLV-I Tax protein, no apoptosis was de-Southern blot analysis. The restriction endonuclease
SacI cleaves a single site in each LTR and releases an tected by analysis of specific oligonucleosomal DNA
fragmentation.8.4-kb fragment characteristic of a full-length provirus.
As shown in Fig. 1b, the 8.4-kb fragment was present in Apoptosis induced by Tax was effectively prevented
by expression of Bcl-2 (Yamada et al., 1994), a proto-the endothelial cell lines CR4 (lane 1), CR5 (lane 2), and
the HTLV-I-immortalized T-cell line 2060 (lane 4) but ab-
sent from the parental cell line ECV (lane 3). Subsequent
digestion using other endonucleases revealed proviral
integration at different, yet distinct sites in these cell lines
(data not shown). As CR4 and CR5 exhibited identical
phenotypes, only results obtained from studies using
CR5 are described here.
The expression of HTLV-I gene products was deter-
mined using total cellular proteins or disrupted particles
recovered from culture medium. The results from these
experiments are illustrated in Fig. 2. Expression of the
viral trans-activator Tax, was examined by Western blot
using a rabbit antiserum directed against the carboxy- FIG. 2. (a) Expression of Tax trans-activator was analyzed by Western
blot using a protein extract from 106 cells and rabbit sera directedterminus of Tax (Tax-C Ab). A protein extract from 2060
against a Tax C-terminal peptide (Tax-C Ab). 2060 (lane 1), CR5 (lane(lane 1) was used for comparison of the level of Tax
2), and ECV (lane 3). (b) Western blot analysis of virus particles concen-expression in the different cell lines (Fig. 2a). Significant
trated from culture medium for the cell lines 2060 (lane 1), Cos cells
Tax protein expression was detected for CR5 (lane 2) but transfected with p4.39 (lane 2), ECV (lane 3), and CR5 (lane 4). Specific
not for the ECV control (lane 3). The culture medium was antigens were resolved on a gradient (12.5–20%) SDS–PAGE gel and
detected using TSP-patient serum and 125I-protein A.then subjected to differential centrifugation in order to
AID VY 8720 / 6a41$$$142 08-13-97 18:16:23 vira AP: VY
50 NICOT, ASTIER-GIN, AND GUILLEMAIN
FIG. 3. (a) Induction of Bcl-2 mRNA expression in CR5. Semiquantitative RT-PCR was performed using 5 mg of total RNA from ECV (lane 2), CR5
(lane 4), and a follicular lymphoma cell line (OCI-Ly8, lane 6) or using RNA treated with RNAse prior to the assay. ECV (lane 1), CR5 (lane 3), and
OCI-Ly8 (lane 5). (b) Analysis of Bcl-2 expression by Western blot analysis. Protein extracts (100 mg) were resolved on a 12.5% SDS–polyacrylamide
gel and the Bcl-2 protein (25 kDa) was detected using a mouse monoclonal antibody and chemiluminescence system (Amersham). Lane 1, ECVneo;
lane 2, ECV; lane 3, CR5; lane 4, OCI Ly8 (20 mg of proteins). (c) Southern blot analysis of the major breakpoint region (mbr) of the Bcl-2 gene. Ten
micrograms of high molecular genomic DNA from CR4 (lanes 1–3), CR5 (lanes 4–6), and ECV (lanes 7–9) was digested with the restriction
endonucleases: HindIII (lanes 1, 4, and 7), SacI (lanes 2, 5, and 8), or EcoRI (lanes 3, 6, and 9), electrophoresed on a 0.6% agarose gel, transferred
to a nylon membrane, and hybridized against a Bcl-2 specific, radiolabeled probe (pFL1).
oncogene discovered as a result of the analysis of the sion in CR5 was not related to a rearrangement of this
gene subsequent to proviral integration, Southern blotspecific chromosomal translocation t(14;18) in follicular
lymphoma cells (Tsujimoto et al., 1984). Although Bcl-2 analysis of the major break point clustering region (mbr)
was performed. Results presented in Fig. 3c exhibitedis normally not expressed in human endothelial cells
(Hockenbery et al., 1991; Lebrun et al., 1993; Lu et al., the same restriction fragment profile for CR4 (lanes 1, 2,
and 3), CR5 (lanes 4, 5, and 6) harboring p4.39, as well1993), its expression was investigated in CR5 as an anti-
apoptosis gene candidate whose expression might be as the parental ECV cell line (lanes 7, 8, and 9), indicative
that no rearrangement of the Bcl-2 gene occurred follow-aberrantly affected by HTLV-I. Total RNA from ECV, CR5,
and a follicular lymphoma cell line constitutively express- ing integration of the viral genome. As identical results
were obtained for two HTLV-I-producing cell lines (CR4;ing Bcl-2 (OCI-Ly8), were extracted and subjected to sem-
iquantitative RT-PCR (Fig. 3; lanes 2, 4, and 6). To verify CR5) in which the p4.39 provirus is integrated in different
regions of the genome, we conclude that Bcl-2 expres-that the amplified fragment was not due to DNA contami-
nation, the primers were designed to anneal within two sion does not result from cis-activation due to site-spe-
cific integration. HTLV-I Tax is known to affect the expres-distinct exons; a negative control was performed in paral-
lel for each sample by treatment with RNase prior to the sion of numerous cellular genes and thus has been
tested as a candidate for Bcl-2 up-regulation in CR5 cells.assay (lanes 1, 3, and 5). Southern blot analysis, using
an internal probe revealed specific enhancement of Bcl-
2 mRNA in CR5 (lane 4) as compared to ECV (lane 2). In
order to examine Bcl-2 overexpression in HTLV-I-infected
endothelial cells, ECV and the HTLV-I-producing cell line
CR5 were subjected to immunohistochemistry analyses
using a mouse monoclonal antibody directed against the
oncoprotein Bcl-2. In contrast with ECV, where only a
weak signal was detected, most CR5 cells exhibited an
intense signal (data not shown). Expression of Bcl-2 was
further confirmed by Western blot analysis (Fig. 3b). While
no expression was detected for ECVneo (lane 1) or ECV FIG. 4. (a) CAT assay performed for ECV cells transiently trans-
(lane 2), a specific band migrating at 25 kDa was de- fected with Bcl-2-CAT (P1P2-CAT) or HTLV-I LTR-CAT in the presence
tected with a Bcl-2 monoclonal antibody in CR5 (lane 3) or absence of a Tax-expression construct. Abbreviations: CM, chlor-
amphenicol; AcCM, acetylated chloramphenicol. (b) Western blotand the positive control OCI (lane 4). As expected, these
analysis of Tax and Bcl-2 expression in the cadmnium inducible JPX9results demonstrate that Bcl-2 activation in CR5 was not
cell line and control JPXm3 cells. Proteins were resolved on a 12.5%
related to the presence of PVV1 or neomycin-selection, SDS– polyacrylamide gel and subsequently transferred onto a nylon
but rather to the presence of HTLV-I. membrane. Tax and Bcl-2 expression were detected using chemilumi-
nescence.In order to demonstrate that activation of Bcl-2 expres-
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TABLE 1
Sequences of Oligonucleotides Used for Polymerase Chain Reaction
Upstream primers Downstream primers Internal probes
pol a: 5=GGATCCCACAAG pol b: 5=GCGTCATCTGAT pol p: 5=ATCCTTCTCAAG
TCTCTACTGTGCC CAGGTTCTTAAG TTCAATCATTAG
TGCAGCTGCG
tax 1: 5=CGGATACCCAGT tax 2: 5=GAGCCGATAACG pX a: 5=GAATTCGAGCAT
CTACGT CGTCCATCG CAGATCACCTGG
bcl a: 5=GTGTGTGGAGAG bcl b: 5=GGTGATGCAAGC bcl p: 5=CTGGATCCAGGA
CGTCAACC TCCCACC TAACGGAG
The parental ECV cells were transiently transfected with the control ECV cell line, no morphological changes were
observed. Consistently, oligonucleosomal DNA fragmen-a reporter construct containing the chloramphenicol ace-
tyl-transferase (CAT) gene under the control of Bcl-2 pro- tation was not detected in these cells.
Bcl-2 expression was investigated in CR5 cells, asmoters, P1P2-CAT (Zauli et al., 1995), in the presence or
absence of a Tax-expressing vector (Fig. 4a). As a control reports by others have demonstrated that this oncopro-
tein is capable of inhibiting Tax-mediated apoptosis. Bcl-for transfection efficiency, the Tax vector was also trans-
fected with an HTLV-I-LTR-CAT construct. While an in- 2 is not normally expressed at significant levels in human
endothelial cells. In CR5 cells, however, we were ablecrease in CAT activity was observed with the HTLV-I-
LTR (lanes 3 and 4), no significant activation could be to show specific activation of Bcl-2 expression by semi-
quantitative RT-PCR, immunohistochemistry, and West-detected with P1P2-CAT (lanes 1 and 2). This observation
was additionally verified using the Tax-inducible cell line, ern blot analysis. Dysregulation of Bcl-2 in human B-cell
lymphoma occurs in more than 80% of these cases afterJPX9. Induction of Tax expression by CdCl2 (upper right
panel) did not significantly activate Bcl-2 (lower right rearrangement at the major breakpoint region. Southern
analysis revealed that Bcl-2 activation in two cell linespanel) as compared to effects of the same treatment
on the control cell line JPX-m3 (Fig. 4b). Therefore, we (CR4 and CR5) does not result in a rearrangement of this
gene. Further, as these clones exhibited different proviralconclude that Tax expression alone is not sufficient for
Bcl-2 activation by HTLV-I, suggesting that this event integration sites, a cis-activation mechanism is not plau-
sible. The HTLV-I trans-activating Tax protein is knownprobably requires an additional viral-encoded protein(s).
to affect expression of numerous cellular genes and was
recently shown to repress the expression of the proapop-DISCUSSION
totic gene, Bax (Brauweiler et al., 1997). Therefore, we
have investigated the potential involvement of Tax in Bcl-Endothelial cells (ECs), like B-cells, dendritic cells, and
2 up-regulation. Our results indicate that Tax alone is notmonocytes, interact with T-cells at the onset of various
sufficient for a significant increase in Bcl-2 expressionimmune responses. ECs express costimulatory factors
and probably requires an additional viral protein(s).and, when induced by IFN-g to express class II major
Induction of Bcl-2 might protect ECs from virus-in-histocompatibility complex molecules, can induce prolif-
duced apoptosis and thereby facilitate viral gene expres-eration of allogeneic CD4/ T-cells (Pober et al., 1983;
sion. Interestingly, it has been proposed that in TSP/Hughes et al., 1990). HTLV-I-related diseases (ATL;TSP/
HAM patients, Tax released from infected cells inducesHAM) are characterized by an aggressive CD4/ lympho-
cytokines released by microglia and contributes to demy-proliferation. Although HTLV-I is generally considered to
elination and inflammation even in the absence of detect-be a T-lymphotropic virus, our laboratory and others have
able virus in the CNS (Dhib-Jalbut et al., 1994). Further-noted a diverse population of cell types that are effec-
more, Tax expression in brain-specific EC has beentively infected in vitro. Only transient expression has
shown to cause hyperproduction of inflammatory cyto-been detected in these experiments and, in most cases,
kines such as IL6, TNFa, IFNg, and GM-CSF, which arethe cells subsequently undergo apoptosis (C. Nicot, un-
also found at high levels in the serum and cerebrospinalpublished observations). In the present study we have
fluid of patients with TSP/HAM (Rott et al., 1993; Naka-reported a human endothelial cell line, CR5, that is chron-
mura et al., 1996). Results presented here and those ofically infected by HTLV-I. The presence of a full-length
previous reports suggest that EC are potential targetsprovirus has been demonstrated by Southern analysis
for HTLV-I infection and replication. Infection of EC mayand stable expression of viral antigens, as well as the
produce local inflammation resulting in demyelination ortrans-activating Tax protein has been verified by Western
blot. Despite the fact that CR5 cells grew slower than T cell-infiltration into the CNS and may play an important
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motifs of inhibitory factor kappa B and induces nuclear translocationrole in the clinical course of TSP/HAM pathogenesis. Our
of transcription factor NF-kappa B proteins for transcriptional activa-results establish a relationship between HTLV-I and Bcl-
tion. Proc. Natl. Acad. Sci. USA 91, 3584–3588.
2 expression in human EC. Further experiments will be Hildreth, J. E., Subramanium, A., and Hampton, R. A. (1997). Human T-
required to explain the mechanism and significance of cell lymphotropic virus type I (HTLV-1)-induced syncytium formation
mediated by vascular cell adhesion molecule-1: Evidence for involve-this observation with respect to HTLV-I infection, replica-
ment of cell adhesion molecules in HTLV-1 biology. J. Virol. 71, 1173–tion, and pathogenesis.
1180.
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